World Drug Manufacturing Summit 2010

Berlin, Germany
30th November – 2nd December 2010

Increasing innovation and reducing costs across global operations.

World Drug Manufacturing 2010 will debate the latest industry challenges occurring throughout small molecule and biologic manufacturing. The industry is facing increasing pressure to reduce costs, in order to remain competitive against generics. It is therefore more important than ever that companies reduce waste, streamline processes and increase their global presence.

The programme for World Drug Manufacturing 2010 is well underway with leading speakers lined up from Novartis, Pfizer, Merck Sharp and Dohme and NIPTE dealing with issues such as:

• Cost reduction through sustainable manufacturing strategies
• Implementing next generation continuous manufacturing technologies
• Developing a streamlined and consistent global supply network
• Combining lean and Quality by Design
• Balancing compliance and cost
• Managing technology transfer across sites and organisations
• Identifying and engaging global suppliers and CMO’s
• Influencing COGS throughout the product development and manufacturing lifecycle

If there are any themes you would like to see covered in addition to the above or would like to join our panel to help develop the programme to ensure it truly reflects the needs of the industry, please contact us

2009 Confirmed Speakers included:
	Gerald Heddell Director, Inspection and Enforcement MHRA		Twan Kersten Associate Director, Business Excellence Johnson & Johnson
	Valerio Trifoni , Finance and Controlling Director, Technical Operations Ferring Pharmaceuticals		Jonathan Walker Head, cLEAN® Program and Master Black Belt Novo Nordisk Pharmaceuticals
	Liam Dunne Director, Process Development and Commercialisation Merck Sharp & Dohme Ltd		Thurloch O'Criodain Senior Director, Quality Centocor